Components of metabolic syndrome and prognosis of renal cell cancer

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386.
   PubMed Web of Science ®Google Scholar
• Hakimi AA, Furberg H, Zabor EC, et al. An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma. J Natl Cancer Inst. 2013;105:1862–1870.
   PubMed Web of Science ®Google Scholar
• Lipworth L, Tarone RE, Lund L, et al. Epidemiologic characteristics and risk factors for renal cell cancer. Clin Epidemiol. 2009;1:33–43.
   PubMedGoogle Scholar
• Chen L, Li H, Gu L, et al. The impact of diabetes mellitus on renal cell carcinoma prognosis: a meta-analysis of cohort studies. Medicine (Baltimore). 2015;94:e1055.
   PubMed Web of Science ®Google Scholar
• Flaherty KT, Fuchs CS, Colditz GA, et al. A prospective study of body mass index, hypertension, and smoking and the risk of renal cell carcinoma (United States). Cancer Causes Control. 2005;16:1099–1106.
   PubMed Web of Science ®Google Scholar
• Haggstrom C, Rapp K, Stocks T, et al. Metabolic factors associated with risk of renal cell carcinoma. PLoS ONE. 2013;8:e57475.
   PubMed Web of Science ®Google Scholar
• Kocher NJ, Rjepaj C, Robyak H, et al. Hypertension is the primary component of metabolic syndrome associated with pathologic features of kidney cancer. World J Urol. 2017;35:67–72.
   PubMed Web of Science ®Google Scholar
• Field AE, Coakley EH, Must A, et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med. 2001;161:1581–1586.
   PubMed Web of Science ®Google Scholar
• Aguilar M, Bhuket T, Torres S, et al. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA. 2015;313:1973–1974.
   PubMed Web of Science ®Google Scholar
• Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol. 1994;33:365–369.
   PubMed Web of Science ®Google Scholar
• Care Register for Health Care. 2016. Available from: https://www.thl.fi/fi/tilastot/tiedonkeruut/hoitoilmoitusjarjestelma-hilmo, last visited 11.4.2017
   Google Scholar
• Horiguchi A, Asano T, Asano T, et al. Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma. J Urol. 2008;180:1137–1140.
   PubMed Web of Science ®Google Scholar
• Lee WK, Hong SK, Lee S, et al. Prognostic value of body mass index according to histologic subtype in nonmetastatic renal cell carcinoma: a large cohort analysis. Clin Genitourin Cancer. 2015;13:461–468.
   PubMed Web of Science ®Google Scholar
• Choi Y, Park B, Jeong BC, et al. Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis. Int J Cancer. 2013;132:625–634.
   PubMed Web of Science ®Google Scholar
• Lee HW, Jeong BC, Seo SI, et al. Prognostic significance of visceral obesity in patients with advanced renal cell carcinoma undergoing nephrectomy. Int J Urol. 2015;22:455–461.
   PubMed Web of Science ®Google Scholar
• Persky S, de Heer HD, McBride CM, et al. The role of weight, race, and health care experiences in care use among young men and women. Obesity (Silver Spring). 2014;22:1194–1200.
   PubMed Web of Science ®Google Scholar
• Booth HP, Prevost AT, Gulliford MC. Impact of body mass index on prevalence of multimorbidity in primary care: cohort study. Fam Pract. 2014;31:38–43.
   PubMed Web of Science ®Google Scholar
• Simone S, Gorin Y, Velagapudi C, et al. Mechanism of oxidative DNA damage in diabetes: tuberin inactivation and downregulation of DNA repair enzyme 8-oxo-7,8-dihydro-2'-deoxyguanosine-DNA glycosylase. Diabetes. 2008;57:2626–2636.
   PubMed Web of Science ®Google Scholar
• Zelenko Z, Gallagher EJ. Diabetes and cancer. Endocrinol Metab Clin North Am. 2014;43:167–185.
   PubMed Web of Science ®Google Scholar
• Lee S, Hong SK, Kwak C, et al. Prognostic significance of diabetes mellitus in localized renal cell carcinoma. Jpn J Clin Oncol. 2012;42:318–324.
   PubMed Web of Science ®Google Scholar
• Weikert S, Boeing H, Pischon T, et al. Blood pressure and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition. Am J Epidemiol. 2008;167:438–446.
   PubMed Web of Science ®Google Scholar
• Zhang C, Yu L, Xu T, et al. Association of dyslipidemia with renal cell carcinoma: a 1ratio2 matched case-control study. PLoS One. 2013;8:e59796.
   PubMed Web of Science ®Google Scholar
• Pottegard A, Clark P, Friis S, et al. Long-term use of statins and risk of renal cell carcinoma: a population-based case-control study. Eur Urol. 2016;69:877–882.
   PubMed Web of Science ®Google Scholar
• de Martino M, Leitner CV, Seemann C, et al. Preoperative serum cholesterol is an independent prognostic factor for patients with renal cell carcinoma (RCC). BJU Int. 2015;115:397–404.
   PubMed Web of Science ®Google Scholar
• Ohno Y, Nakashima J, Nakagami Y, et al. Clinical implications of preoperative serum total cholesterol in patients with clear cell renal cell carcinoma. Urology. 2014;83:154–158.
   PubMed Web of Science ®Google Scholar
• Kaffenberger SD, Lin-Tsai O, Stratton KL, et al. Statin use is associated with improved survival in patients undergoing surgery for renal cell carcinoma. Urol Oncol. 2015;33:21.e11–21.e17.
   Web of Science ®Google Scholar
• Fang Z, Tang Y, Fang J, et al. Simvastatin inhibits renal cancer cell growth and metastasis via AKT/mTOR, ERK and JAK2/STAT3 Pathway. PLoS One. 2013;8:e62823.
   PubMed Web of Science ®Google Scholar
• Ahn J, Lim U, Weinstein SJ, et al. Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer. Cancer Epidemiol Biomarkers Prev. 2009;18:2814–2821.
   PubMed Web of Science ®Google Scholar
• Sherwin RW, Wentworth DN, Cutler JA, et al. Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial. JAMA. 1987;257:943–948.
   PubMed Web of Science ®Google Scholar